In addition to ligation of the T cell antigen receptor (TCR), activation of the CD28 coreceptor by the costimulatory molecule B7 is required for induction of the transcription factor NF-jB and robust T cell activation, although the contribution of CD28 to this process remains incompletely understood. We show here that phosphoinositide-dependent kinase 1 (PDK1) is essential for integrating the TCR and CD28 signals. After we deleted PDK1 from T cells, TCR-CD28 signals were unable to induce activation of NF-jB or phosphorylation of protein kinase C-h, although T cell survival and pathways dependent on the kinases p38 and Jnk or the transcription factor NFAT were unaffected. CD28 facilitated NF-jB activation by regulating recruitment and phosphorylation of PDK1, which are necessary for efficient binding of PDK1 to protein kinase C-h and the adaptor CARMA1 and thus for NF-jB induction.
In addition to ligation of the T cell antigen receptor (TCR), activation of the CD28 coreceptor by the costimulatory molecule B7 is required for induction of the transcription factor NF-jB and robust T cell activation, although the contribution of CD28 to this process remains incompletely understood. We show here that phosphoinositide-dependent kinase 1 (PDK1) is essential for integrating the TCR and CD28 signals. After we deleted PDK1 from T cells, TCR-CD28 signals were unable to induce activation of NF-jB or phosphorylation of protein kinase C-h, although T cell survival and pathways dependent on the kinases p38 and Jnk or the transcription factor NFAT were unaffected. CD28 facilitated NF-jB activation by regulating recruitment and phosphorylation of PDK1, which are necessary for efficient binding of PDK1 to protein kinase C-h and the adaptor CARMA1 and thus for NF-jB induction.
Engagement of the T cell antigen receptor (TCR) by foreign antigen bound to major histocompatibility complex activates CD4 + T helper cells through several signaling pathways. These pathways induce the proliferation of activated T cells and promote their differentiation into effector T helper type 1 and 2 cells and memory cells 1 . Ligation of the coreceptor CD28 (A000548), along with TCR signaling, is required for full activation of T cells 2, 3 . Ligation of CD28 is required for efficient activation of the transcription factors NF-kB 3 , NFAT 4 and AP-1 (ref. 5 ) and for the production of cytokines regulated by these transcription factors. Consequently, the immune response to foreign antigen is much lower in CD28-deficient (Cd28 -/-) mice 6, 7 . The key 'downstream' effector of CD28 ligation is phosphatidylinositol-3-OH kinase (PI(3)K). Although pharmacological and genetic studies have shown the importance of this kinase in T cell activation 8 , it is still unclear whether CD28 triggers a distinct signaling cascade or whether signals from CD28 and PI(3)K act in synergy with pathways that emanate from the TCR. PDK1 (A001740), a pleckstrin homology domain-containing protein kinase, is a well characterized downstream effector of PI(3)K that may act as a 'master regulator' of the protein kinase A-protein kinase G-protein kinase C (PKC) family 9 . After activation, PI(3)K converts the membrane phospholipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P 2 ) into phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ) through phosphorylation 10 . PtdIns (3, 4, 5 )P 3 then functions as a secondary messenger for proteins containing pleckstrin homology domains 10 . It is believed that PI(3)K does not affect PDK1 through direct phosphorylation; instead, through generation of PtdIns(3,4,5)P 3 , PI(3)K induces relocalization of PDK1 to phospholipid-enriched membrane fractions 9, 11 . The mechanism by which PDK1 is activated remains unclear, and some reports have claimed that PDK1 is constitutively active 9, 11 . Several serine and threonine residues in PDK1 are reportedly phosphorylated 12, 13 , although the consequence of these post-translational modifications and the kinase(s) responsible remain to be defined. In any case, it is known that activated PDK1 can phosphorylate substrate kinases such as Akt, which through its own pleckstrin homology domain also localizes to PtdIns(3,4,5)P 3 -enriched membranes. Other PDK1 substrates such as PKC do not have pleckstrin homology domains, and hence their localization together with PDK1 occurs through as-yetuncharacterized mechanisms 9 .
The kinases activated by PDK1 are important for cell metabolism, survival and activation, so it is not unexpected that PDK1-knockout embryos die early in gestation 14 . In the immune system, conditional deletion of PDK1 in developing thymocytes blocks T cell development at the double-negative 4 (DN4) stage through prevention of the proliferation of DN4 thymocytes 15 . However, the inability to isolate PDK1-deficient mature T cells has prevented the analysis of PDK1 function in T cell activation. Treatment of Jurkat T cells with short hairpin RNA has shown that PDK1 serves a crucial function in T cell activation by nucleating the assembly of a signaling complex in response to CD28 engagement, thereby leading to activation of NF-kB 16 . However, lack of the tumor suppressor PTEN, a crucial PI(3)K regulator, in Jurkat T cells has led to questions about the relevance of these findings to primary T cells. In addition, controversy about the status of the phosphorylation of PKC-y (A001933) has led to further confusion about the function of PDK1 in TCR-and CD28mediated activation of NF-kB 16 .
In this study, using a mouse with a T cell-specific deletion of Pdk1, we found that TCR-and CD28-mediated NF-kB activation was abolished in the absence of PDK1, whereas other signaling pathways involving NFAT and the kinases MAPK and Jnk were not substantially affected. In addition, somewhat unexpectedly, survival of CD4 + T cells was not affected, even though PDK1 is thought to be important for cell growth and metabolism. Given our findings, we propose that CD3 ligation regulates mainly PKC-y localization, whereas CD28 ligation is required for PDK1 localization; CD28 ligation leads to PDK1 phosphorylation on Thr513 through a PI(3)K-dependent pathway; and the phosphorylation of PDK1 at Thr513 is crucial for binding of PDK1 to both PKC-y and the adaptor CARMA1 (A003863), a MAGUK-domain family member, which are essential for NF-kB activation. Our study provides convincing genetic evidence for the importance of PDK1 in integrating signals from the TCR and CD28, leading to NF-kB activation.
RESULTS

CD4 + T cell activation requires PDK1
To clarify the function of PDK1 in primary T cells, we crossed mice in which Pdk1 was flanked by loxP sites (Pdk1 flox/flox ) with transgenic mice expressing Cre recombinase under control of the Cd4 promoter (Tg(CD4-cre)1Cwi; called 'CD4-Cre' here) to delete Pdk1 from T cells at the double-positive stage of development. Unlike deletion of Pdk1 by Cre under control of the Lck promoter, which leads to a block in thymocyte development between the DN3 and DN4 stages 15 , deletion of Pdk1 by CD4-Cre at the double-positive stage did not substantially affect CD4 + T cell development ( Fig. 1a,b ), even though these cells had much less PDK1 protein than did control cells from wild-type littermates ( Fig. 1c) . Moreover, total number of thymocytes and lymph node T cells was not altered much. The proportion of CD4 + T cells was slightly lower in PDK1-deficient mice than in their wildtype littermates, in both peripheral blood and lymph nodes. The number and proportion of CD8 + T cells were notably lower in the thymus of the T cell-specific PDK1-deficient mice than in the thymus of wild-type littermates; this decrease in numbers was maintained in the periphery (Fig. 1a,b ). This could have been a consequence of Pdk1 deletion in double-positive thymocytes that for unknown reasons disproportionately affected CD8 + T cell development. In addition, we found that other Thy1 + cell types, including gd T cells and natural killer cells, were more abundant in the periphery (S.-G.P. and S.G., unpublished observations). We isolated mature CD4 + single-positive thymocytes by flow cytometry and stimulated the cells with antibody to CD3 (anti-CD3) and anti-CD28. In the absence of PDK1, upregulation of CD25 and production of interleukin 2 (IL-2) were considerably impaired ( Fig. 1d,e ).
CD4 + T cell survival does not require PDK1
As PDK1 has been linked to cell survival-signaling pathways, such as those involving Akt, we wanted to compare the survival kinetics of PDK1-deficient CD4 + single-positive thymocytes and peripheral CD4 + T cells. We therefore analyzed the population of dead cells by staining them with 7-amino-actinomycin D (7-AAD) and annexin V after culturing the thymocytes for 3 d or 6 d with or without IL-7. The survival of mature CD4 + single-positive thymocytes was not much lower for PDK1-deficient cells than wild-type cells, and the survival of PDK1-deficient mature thymocytes was enhanced by IL-7 treatment ( Fig. 2a ), which suggests that PDK1 is not involved in IL-7-mediated survival of thymocytes. To address the function of PDK1 in T cell survival in vivo, we generated mice bearing the congenic markers Thy-1.1 and Thy-1.2. The transfer of wild-type or PDK1-deficient CD4 + cells into recipient mice did not affect the survival of either cell type ( Fig. 2b) . Annexin V-positive apoptotic cells in lymph nodes were not substantially different in wild-type versus knockout mice (data not shown). These data suggest that PDK1 is not essential for the survival of resting CD4 + T cells.
To assess the function of PDK1 in the survival of CD8 + T cells, we isolated CD8 + T cells from Pdk1 flox/flox or Pdk1 +/+ mice and infected them with Cre-expressing retroviruses. Similar to CD4 + T cells, the survival of CD8 + T cells was not affected much by PDK1 deficiency (Fig. 2c) , even though the number of CD8 + T cells was much lower in PDK1-deficient mice ( Fig. 1a,b ). This suggests that the decrease in CD8 + T cells was caused by a block in the development of these cells.
TCR-CD28-mediated NF-jB activation requires PDK1
Ligation of TCR and CD28 results in the activation of many pathways, including those involving NF-kB, NFAT, Jnk and the MAPK p38 (refs. 17,18) . We therefore examined the status of those pathways after ligation of TCR and CD28 in primary CD4 + T cells isolated from lymph nodes of Pdk1 flox/flox ; CD4-Cre or Pdk1 +/flox ; CD4-Cre mice. Receptor ligation-induced degradation of the NF-kB inhibitor IkBa ( Fig. 3a) and NF-kB DNA-binding activity (Fig. 3b) were inhibited in PDK1-deficient cells, despite relatively normal phosphorylation of Jnk and p38 ( Fig. 3a ) and activation of NFAT ( Fig. 3b ). Consistent with our previous findings 16 , induced phosphorylation of PKC-y at Thr538 was also considerably impaired in the absence of PDK1 (Fig. 3a) . The pattern of signaling defects resembled that reported for mature T cells from PKC-y-deficient (Prkcq -/-) mice 19 . PKC-y-deficient cells are defective in NF-kB activation but not in other signaling pathways, such as those involving Jnk, p38 and NFAT 19 ( Supplementary Fig. 1  online) . Notably, PDK1-deficient CD4 + T cells had slightly less PKC-y than did wild-type cells ( Fig. 3a) , which suggested that PDK1 is involved in the stability of PKC-y in activated cells. We also examined the status of phosphorylation of Akt, another substrate of PDK1. Phosphorylation of Thr308 in the activation loop of Akt was impaired after deletion of PDK1, but phosphorylation of Ser473 in the hydrophobic region was not affected ( Supplementary Fig. 2 online) . Expression of IL-2, one of the key NF-kB-dependent targets in T cells, was also much lower in PDK1-deficient primary CD4 + T cells than in wild-type cells (Fig. 3c) . The lower IL-2 expression, however, was not caused by destabilization of IL-2 mRNA (Supplementary Fig. 3 online). Whereas PDK1 deficiency did not affect survival much, proliferation of CD4 + T cells was much lower in the absence of PDK1 after stimulation with anti-CD3 and anti-CD28 ( Fig. 3d) . To address the concern that mature T cells that develop in the absence of PDK1 are somehow different from normal T cells, we also deleted PDK1 in mature T cells from Pdk1 flox/flox mice by transducing the T cells with a Cre-expressing recombinant retrovirus (Fig. 3e,f and Supplementary Fig. 4 online). The CD4 + T cells with PDK1 deletion, detected by internal ribosome entry site-driven expression of green fluorescent protein (GFP), did not upregulate the activation marker CD69, further linking PDK1 to TCR-CD28mediated T cell activation ( Fig. 3e) .
Given the available data indicating differences in TCR signaling to NF-kB in naive and effector T cells, we next assessed the function of PDK1 in effector T cells. This is an important issue, as the kinase TAK1 (A002249), a crucial regulator of cytokine-induced NF-kB pathways, is required for TCR-mediated signaling in naive T cells, whereas in effector T cells it participates in cytokine-mediated survival signaling but not TCR signaling to NF-kB 17 . However, as a result of the inability of Pdk1 -/cells to signal to NF-kB, deletion of Pdk1 during T cell development leads to a CD4 + T cell population that cannot become effector cells. We therefore isolated splenic CD4 + T cells from Pdk1 flox/flox or Pdk1 +/+ mice and activated the isolated cells with concanavalin A to convert them into CD25 hi CD44 hi effector T cells (data not shown). We then infected the cells with Creexpressing retroviruses to delete Pdk1. The PDK1-deficient effector T cells, like PDK1-deficient naive T cells, did not activate NF-kB but did activate Jnk and p38 in response to TCR stimulation ( Fig. 3f) . IL-2 production was also inhibited in PDK1-deficient effector CD4 + T cells ( Supplementary Fig. 4 ). Basal Thr538 phosphorylation is much higher in effector T cells than in naive cells; the relative increase in Thr538 phosphorylation after stimulation is therefore less than that in naive cells. The greater basal PKC-y phosphorylation, however, was dependent on PDK1 ( Fig. 3f ). Effector T cells are less dependent on CD28 signals for activation, so it is likely that effector T cells compensate for the requirement for CD28 during NF-kB activation by maintaining a constitutive PDK1-PKC-y activation cascade.
To further establish the function of PDK1 in effector T cells, we crossed Pdk1 flox/flox mice with transgenic mice expressing Cre from an estrogen receptor-dependent cassette (Tg(CAG-cre/Esr1)5Amc; called 'ER-Cre' here). We treated effector T cells isolated from these mice with tamoxifen to delete Pdk1. These PDK1-deficient cells had the same pattern of signaling defects as Pdk1 flox/flox ; CD4-Cre mice: an inability to activate NF-kB or produce IL-2, but normal activation of Jnk and MAPK ( Supplementary Fig. 5 online) . Further analysis of these cells showed that PDK1 was dispensable for both intrinsic survival and IL-2-dependent survival ( Supplementary Fig. 6 online) . Thus, PDK1 functions in TCR-induced activation of NF-kB in both naive and effector T cells.
CD28 regulates PDK1 localization and phosphorylation
The TCR complex and CD28 localize together at the central supramolecular activation cluster (cSMAC) 20 after stimulation of T cells; this colocalization is necessary for strong NF-kB activation 3 (Supplementary Fig. 7 online). We found that PDK1 and PKC-y also localized together at the immunological synapse following stimulation of primary CD4 + T cells ( Fig. 4a and Supplementary Fig. 8 online) . PDK1 is activated ( Fig. 4b) and is immunoprecipitated together with PKC-y after stimulation of Jurkat T cells ( Fig. 4c ) and primary CD4 + T cells ( Supplementary Fig. 9 online) with anti-CD3 and anti-CD28. Notably, despite the interaction between PDK1 and PKC-y after stimulation with anti-CD3 and anti-CD28, recruitment of PDK1 and PKC-y can occur independently; that is, treatment with anti-CD3 alone led to PKC-y recruitment, whereas treatment with anti-CD28 alone led to PDK1 recruitment ( Fig. 4a ). However, engagement of both CD3 and CD28 was required for induced phosphorylation of PKC-y ( Fig. 4c and Supplementary Fig. 10 online). Costimulation with CD3 and CD28 also resulted in more recruitment of PDK1 and PKC-y than did stimulation with either antibody alone ( Fig. 4a ). Ligation of TCR or CD28 therefore independently induces the recruitment of PKC-y and PDK1, respectively. These data indicate that T cell coreceptor ligation is crucial for the recruitment of PDK1 to the cSMAC, yet they do not address whether PDK1 kinase activity is also regulated by CD28 signaling. Notably, besides the localization of PDK1 and PKC-y to the cSMAC, small amounts of both PDK1 and PKC-y could be detected at the region opposite to the cSMAC, called the 'antisynapse' . However, the importance of this localization remains unclear. After activation by CD28 ligation, PI(3)K converts the phospholipid PtdIns(4,5)P 2 into PtdIns(3,4,5)P 3 , which regulates PDK1 function, although the mechanism remains somewhat controversial. One group has reported that PDK1 kinase activity and phosphorylation status remain unchanged after signaling 9, 21 . However, others have reported that PDK1 is phosphorylated after signaling 12, 13 and that PtdIns(3,4,5)P 3 can induce PDK1 autophosphorylation in vitro, leading to more PDK1 activity 22 . In our study, stimulation with anti-CD3 and anti-CD28 increased PDK1 kinase activity (Fig. 4b) . Furthermore, whereas PtdIns(3,4,5)P 3 increased PDK1 kinase activity, PtdIns(4,5)P 2 inhibited PDK1 kinase activity in vitro (Fig. 4b) . Moreover, ligation of both CD28 and CD3-CD28 induced the appearance of a slowermigrating form of PDK1 ( Fig. 4c and Supplementary Fig. 10 ). This slower-migrating band represented a phosphorylated form of PDK1, as treatment with phosphatase reversed the shift in mobility (Supplementary Fig. 11 online) . Ser241 in PDK1 has been shown to be phosphorylated, but it is not the site of CD3-CD28-induced phosphorylation, as an antibody to phosphorylated Ser241 detected PDK1 in unstimulated cells (Fig. 4c) .
To test whether TCR-CD28-mediated PDK1 phosphorylation is dependent on PI(3)K, we analyzed PDK1 phosphorylation in cells treated with the PI(3)K inhibitors wortmannin, LY294002 and PI(3)K-g inhibitor II. PDK1 phosphorylation was inhibited by wortmannin and LY294002 (Fig. 4d) . PKC-y phosphorylation and IkBa degradation, which we found to be dependent on PDK1, were also blocked by wortmannin and LY294002. However, PI(3)K-g inhibitor II did not affect PDK1 phosphorylation, PKC-y phosphorylation or IkBa degradation. IL-2 production in mouse T cells was similarly inhibited by wortmannin and LY294002 but not by PI(3)K-g inhibitor II (Fig. 4e) . These findings suggest that PI(3)K-mediated phosphorylation of PDK1 is directly linked to TCR-CD28-mediated activation of NF-kB, which does not involve the g-subunit of PI(3)K. Similarly, a published report has shown that alteration of the PI(3)K-binding site on CD28 blocks NF-kB activation 23 .
Phosphorylation of PDK1 at Thr513
We found that PDK1 bound to PKC-y in primary T cells (Supplementary Fig. 9 ) and Jurkat T cells 16 (Fig. 4c) . Moreover, PDK1 can induce weak PKC-y phosphorylation in vitro, which is associated with the relatively weak binding between these proteins in in vitro conditions. The weak PDK1-PKC-y interaction noted in vitro and by overexpression, and the association between CD28-induced PDK1 phosphorylation and PKC-y coimmunoprecipitation, suggested that induced PDK1 phosphorylation augments PDK1-PKC-y interactions. We therefore hypothesized that TCR-CD28-mediated phosphorylation of PDK1 is an important regulatory step for the induction of PKC-y-mediated NF-kB activation. To test our hypothesis, we sought to identify the PDK1-phosphorylation site that affects the binding between PDK1 and PKC-y. We systematically assessed the contribution of 11 previously identified PDK1 phosphorylation sites to PKC-y binding by substituting them with alanine residues. We then analyzed binding between PKC-y and all 11 PDK1 mutants, and found that one, the T513A mutant, was most affected in its binding to PKC-y ( Supplementary Fig. 12 online) . Alignment of sequences surrounding Thr513 with PDK1 sequences from other species indicated that Thr513 is highly evolutionarily conserved. Notably, this site is also conserved in Akt family members ( Fig. 5a and Supplementary Fig. 13 online). After overexpression, wild-type PDK1 bound weakly to PKC-y ( Fig. 5b) and did not result in much more NF-kB activation induced by overexpression of a complex of PKC-y, CARMA1 and the adaptors Bcl-10 and Malt1 (yCBM; Fig. 5c ). These data indicate that Thr513 phosphorylation is tightly regulated by 'upstream' signals because overexpression of wild-type PDK1 itself was not enough to allow efficient binding to PKC-y and CARMA1 or, hence, yCBMmediated NF-kB activation. However, introduction of a phosphomimetic aspartic acid or glutamic acid residue at Thr513 (T513D or T513E) resulted in considerably enhanced binding to PKC-y ( Fig. 5b) and NF-kB activation induced by yCBM overexpression (Fig. 5c) .
It was unclear from the data reported above how phosphorylation of PDK1 at Thr513, which is well outside the kinase domain, regulates PDK1 function. The T513A alteration induced strong binding between PKC-y and PDK1 (Fig. 5b) but did not increase NF-kB activation by yCBM overexpression (Fig. 5c) . These data suggest that although structural properties of the protein around Thr513 regulate efficient binding to PKC-y, introduction of a negative charge at this site (through phosphorylation or substitution with phosphomimetic amino acids) is specifically required for proper NF-kB activation. This discrepancy between binding of PDK1 to PKC-y (by substitution of Thr513 with aspartic acid or alanine) and the ability of overexpressed PDK1 to activate NF-kB (found only by substitution of Thr513 with aspartic acid) could be explained by the effect of these alterations on interaction of PDK1 with CARMA1. Indeed, we found efficient binding between PDK1 and CARMA1 only after introduction of a negative charge at position 513 (Fig. 5d) . Thus, although the T513A alteration led to strong binding between PDK1 and PKC-y, it did not induce strong NF-kB activation because it did not result in efficient recruitment of CARMA1. CD28-regulated PDK1 phosphorylation is therefore central to activation of NF-kB by PKC-y and CARMA1. Notably, PDK1 was hyperphosphorylated after PKC-y binding (Fig. 5b) but not after CARMA1 binding (Fig. 5d ). We found that this hyperphosphorylation was linked to PKC-y kinase activity, although the exact mechanism remains to be explored.
Requirement of phosphorylated Thr513
To test whether PDK1 is actually phosphorylated after TCR-CD28 ligation, we carried out whole-cell phospholabeling of primary T cells, followed by immunoprecipitation of PDK1 (Fig. 6a) . In parallel, we analyzed the samples by immunoblot with an antibody to phosphorylated Thr513. Treatment of T cells with anti-CD3 and anti-CD28 led to phosphorylation of PDK1 on Thr513. To show that this phosphorylation of PDK1 was dependent on CD28, we stimulated T cells with anti-CD3, anti-CD28 or both, followed by immunoblot analysis with an antibody to phosphorylated Thr513. Thr513 was phosphorylated only after CD28 engagement (Fig. 6b) . However, CD28 ligation alone was unable to result in efficient colocalization of PDK1 and PKC-y (Fig. 4a) , which suggests that signals from the TCR act in synergy with signals from CD28 to activate both PDK1 and PKC-y, resulting in NF-kB activation. Although total PDK1 phosphorylation continued to increase until 60 min after stimulation, Thr513 phosphorylation decreased slightly between 15 and 60 min (Fig. 6a) . This suggests the existence of other CD3-CD28-inducible phosphorylation sites on PDK1, even though Thr513 is the most crucial for NF-kB activation.
To test more directly whether Thr513 of PDK1 is important for TCR-CD28-mediated T cell activation, we reconstituted PDK1deficient T cells with various PDK1 mutants. Although NF-kB activation and IL-2 production after TCR-CD28 ligation were impaired in PDK1 knockouts, these defects were 'rescued' by the introduction of wild-type PDK1 with recombinant lentivirus (Fig. 6c) . Notably, introduction of the PDK1 T513D mutant led to more IL-2 production than did introduction of wild-type PDK1. This was probably because wild-type PDK1 is not phosphorylated in the absence of 'upstream' signal, whereas the T513D mutant mimics the phosphorylated protein, thus demonstrating activity. Conversely, if there are 'upstream' signals, wild-type PDK1 can be phosphorylated at Thr513, but the T513D mutant cannot be further phosphorylated at the site during stimulation. Only T513D localization is redirected by CD28 ligation. The increase in IL-2 production induced by the T513D mutant was therefore limited relative to that induced by wild-type PDK1. Moreover, introduction of the PDK1 T513I mutant, which is defective in binding to PKC-y and CARMA1 and activation of NF-kB and cannot be phosphorylated on Thr513 after TCR-CD28 signaling, did not 'rescue' the defect in IL-2 production after TCR-CD28 receptor ligation. Phosphorylation of PDK1 is required for strong interaction with PKC-y; in the transfection experiment in which we transfected PDK1 constructs into 293 cells, the wild-type PDK1 was unphosphorylated and hence acted like the T513I mutant ( Fig. 5c) .
Complementation with the PDK1 T513D mutant was able to replace CD28 signaling for IL-2 production (Fig. 6c) , which suggested that CD28 signaling leads to PDK1 activation and phosphorylation. However, the induction of IL-2 production in TCR-stimulated cells reconstituted with the PDK1 T513D mutant was augmented by anti-CD28, which indicates that both proper localization and Thr513 phosphorylation of PDK1 are required for efficient signaling. Alternatively, synergy between CD28 and CD3 may be required for the activation of other TCR-induced signaling pathways crucial to IL-2 transcription, such as the NFAT pathway. The data presented above provide strong support for the hypothesis that CD28-induced phosphorylation of PDK1 Thr513 is important for PDK1 regulation during TCR-CD28 signaling ( Supplementary Fig. 14 online) .
DISCUSSION
Activation of NF-kB in T cells has been studied intensely and has identified the involvement of many unique components in this signaling pathway 24 . These include PKC-y and the CBM (CARMA1, Bcl-10 and Malt1) complex. The link between these components and the IkB kinase complex is an area of active investigation and interest; however, the mechanism by which the antigen receptor itself engages this pathway has remained relatively understudied. In particular, a well-established aspect of NF-kB activation in T cells has received very little attention; that is, the obligatory engagement of both CD28 and the TCR to generate robust NF-kB activation. A reason for this dearth of attention has been a lack of information about the signaling pathways triggered by CD28, including confusion about how distinct CD28 signals are integrated with the well-characterized signals from the TCR. Our study has provided convincing evidence that PDK1, a crucial 'downstream' molecule in the CD28-PI(3)K pathway, is the key molecule that integrates the TCR and CD28 signaling pathways, allowing their synergistic action in the activation of NF-kB. On the basis of our findings, we propose the following model of TCR-CD28 signaling to NF-kB. Initially, engagement of the TCR complex with antigen bound to major histocompatibility complex leads to the recruitment of CD28 to the cSMAC region and consequent engagement with the CD28 ligand B7. Activated TCR signaling complexes recruit PKC-y, whereas CD28, through PI(3)Kgenerated PtdIns(3,4,5)P 3 , recruits PDK1, leading to conformational changes induced by autophosphorylation of PDK1 at Thr513. The phosphorylated PDK1 is then able to efficiently bind to both PKC-y and CARMA1. The binding between PDK1 and PKC-y induces phosphorylation of the PKC-y activation loop, and the active PKC-y then induces phosphorylation of CARMA1 (refs. [25] [26] [27] . Phosphorylated CARMA1 undergoes a conformational change that allows it to recruit and assemble the CBM complex and subsequently facilitate activation of IkB kinase and NF-kB. NF-kB activation is dependent on PDK1, whereas other TCR-CD28-mediated pathways, including those of Jnk, p38 and NFAT, are not.
A key finding of our report was the identification of Thr513 as a crucial site whose phosphorylation is necessary to allow PDK1 to efficiently interact with both PKC-y and CARMA1. The ability of PtdIns(3,4,5)P 3 to induce phosphorylation of PDK1 in vitro suggests that Thr513 phosphorylation is an autocatalytic event 22 . Comparison of the sequences of various related kinases, including members of the Akt family, identified a conserved threonine positioned equivalently to Thr513 in PDK1, which suggests that similar autophosphorylation events are a general property of PI(3)K-activated protein kinases. Notably, reconstitution of PDK1-deficient T cells with a mutant form of PDK1 containing a phosphomimetic amino acid substitution at position 513 allowed activation of NF-kB in these cells by TCR engagement alone, which supports the idea that this phosphorylation is important in PDK1 regulation. Phosphorylation at Thr513 probably helps to maintain the PDK1 in a conformation that is triggered by PtdIns(3,4,5)P 3 but more importantly is crucial for efficient recruitment of both PKC-y and CARMA1. However, the presumed conformation change is not sufficient for NF-kB activation, as the T513A mutant, which was also able to bind efficiently to PKC-y, did not efficiently recruit CARMA1 and was therefore unable to efficiently activate NF-kB. Thr513 phosphorylation is therefore the crucial step that allows PDK1 to interact efficiently with both PKC-y and CARMA1, allowing robust NF-kB activation.
An important finding in this report is that survival of T cells was not considerably affected by PDK1 deficiency, but PDK1 was required for T cell activation and proliferation. Moreover, TCR-CD28mediated activation did not induce rapid apoptosis of PDK1-deficient, activated CD4 + T cells. After prolonged stimulation, CD4 + T cell survival was not significantly affected by the absence of PDK1 in the first 48 h. However, stimulation for longer time periods (96 h) led to greater loss of PDK1-deficient T cells than of wild-type cells. This was probably the result of less IL-2 production in PDK1-deficient CD4 + (min)  15  15  60  5   Anti-CD3 +  anti-CD28   700   600   500  V5-PDK1   2,4,5,6 & 7   1 & 3  1 2 3  4 5   WT  ---WT  T513S  T513D  T513I   WT  WT  ---T513S  T513D  T513I   6 T cells, as supplementation with exogenous IL-2 partly reversed the loss of stimulated cells. The incomplete 'rescue' was probably due to lower CD25 expression on the stimulated PDK1-deficient CD4 + T cells. Notably, although it is well known that PDK1 activates Akt through phosphorylation of the activation loop, studies with genetic knockouts have shown different requirements for PDK1 and Akt in thymocyte survival 28 . Whereas double knockout of Akt1 and Akt2 severely affects thymocyte survival 29 , knockout of Pdk1 at an early stage of thymocyte development affects only proliferation of DN4 thymocytes, rather than their survival 15 . It is therefore reasonable to assume that there is an alternative pathway for Akt activation, probably through phosphorylation of Ser473 by the kinase mTOR, that allows survival of PDK1deficient thymocytes and mature CD4 + T cells.
In summary, our findings here have provided definitive genetic and molecular evidence for the crucial function of PDK1 in activation of NF-kB in T cells in response to engagement of both the TCR and CD28. In particular, PDK1 not only directly interacted with and activated PKC-y, but also recruited CARMA1, thereby allowing PKC-y to phosphorylate CARMA1, a crucial step in the subsequent assembly of the CBM complex. An unexpected finding was the apparent lack of dependence on PDK1 of the survival of unstimulated, mature T cells. The specific and restricted function of PDK1 in NF-kB activation in T cells, without significant effect on T cell survival, raises the possibility of developing PDK1-specific inhibitors to block T cell activation in autoimmune diseases and transplantation.
METHODS
Retrovirus and lentivirus transduction. Recombinant retroviruses were produced in Phoenix-Eco cells by transfection of the cells with pMSCV-Cre-IRES-GFP and collection of the recombinant retroviruses 48 h later. Total splenocytes were isolated from wild-type or Pdk1 flox/flox mice and were stimulated with concanavalin A (2 mg/ml) for 24 h. After stimulation, cells were infected with Cre-expressing recombinant retroviruses by spin inoculation. Cells were pretreated with polybrene for 45 min and the medium was removed. Cells were then incubated for 45 min with medium containing recombinant retroviruses and polybrene and were centrifuged for 90 min at 1,000g. After centrifugation, virus-containing medium was removed and cells were cultured in fresh medium. Infected cells were analyzed by flow cytometry or were sorted with a MoFlow (Dako) or FACSAria (BD Biosciences) on the basis of GFP expression. Recombinant lentiviruses were produced according to the the manufacturer's protocol (Invitrogen). Primary CD4 + T cells were isolated from Pdk1 +/+ ; ER-Cre or Pdk1 flox/flox ; ER-Cre mice through negative isolation (Miltenyi Biotec) and cells were incubated with IL-7. After 24 h, cells were infected with each recombinant lentivirus by the spin inoculation method described above. Infected cells were incubated for 4 d with 4-hydroxytamoxifen (100 nM) in medium supplemented with IL-7.
In vivo cell labeling. Isolated CD4 + T cells were washed twice with phosphatefree RPMI 1640 medium and then were incubated for 1 h at 37 1C with 5% CO 2 with phosphate-free RPMI 1640 medium containing 5% (vol/vol) dialyzed FBS. Cells were stimulated with plate-bound anti-mouse CD3e and antimouse CD28 in the presence of 300 mCi [ 32 P]orthophosphate per 3 Â 10 6 cells. After labeling, cells were washed with ice-cold PBS and endogenous PDK1 was immunoprecipitated. The immunoprecipitated PDK1 was analyzed by SDS-PAGE and autoradiography.
NF-jB luciferase assay. HEK293 cells were plated at a density of 2 Â 10 4 cells per well in a 12-well plate and were transfected with plasmids with Lipofectamine 2000 (Invitrogen). Total DNA amounts were normalized to that of empty pCDNA3 vector. After 36 h, cells were lysed in 500 ml TNT lysis buffer (50 mM Tris-HCl, pH7.9) 150 mM NaCl and 1% (vol/vol) Triton X-100) for 10 min at 25 1C. Debris was removed by centrifugation at 18,000g for 5 min at 25 1C. The activity of firefly luciferase and renilla luciferase was measured with 10 ml of lysate for each. The 'fold stimulation' was calculated for each sample by division of the luciferase activity in the sample (normalized to renilla luciferase activity) by the activity of a sample containing only empty expression vector.
In vitro kinase assay. Endogenous PDK1 was immunoprecipitated from Jurkat T cell lysates with anti-PDK1. The immunoprecipitated PDK1 protein was incubated with 10 mCi [g-32 P]ATP for analysis of the autophosphorylation activity of PDK1. In vitro kinase assays were done in 1Â PDK1 in vitro kinase assay buffer containing 1,2-dioleoyl-sn-glycerol-3-phosphocholine and 1,2dioleoyl-sn-glycerol-3-phospho-L-serine 22 .
Coimmunoprecipitation. For precipitation analysis, Myc-tagged PDK1, PDK1 mutants and PDK1 deletion constructs and hemagglutinin-tagged PKC-y and PDK1 pleckstrin homology domains were used. For study of molecular interactions, expression vectors were transfected together into HEK293 cells by Lipofectamine 2000. Then, 40 h later, target proteins were immunoprecipitated with anti-hemagglutinin, anti-PKC-y, anti-PDK1 or anti-c-Myc. Samples were separated by SDS-PAGE and analyzed by immunoblot with antic-Myc, anti-hemagglutinin, anti-PKC-y or anti-PDK1. For study of endogenous interactions, 5 Â 10 7 Jurkat or 1 Â 10 7 primary CD4 + T cells were used after stimulation with or without anti-CD3 and anti-CD28. Cell lysates were immunoprecipitated with anti-PDK1. Samples were separated by SDS-PAGE and analyzed by immunoblot with anti-PKC-y or anti-PDK1.
Immunofluorescence microscopy. For immunofluorescence analysis, Jurkat T cells or primary CD4 + T cells were incubated for 15 min at 37 1C with Dynabead M450 (Invitrogen) coated with anti-CD3, anti-CD28 or both at a ratio of 1:1. After the incubation, T cells conjugated with the Dynabeads were plated for 15 min at 37 1C on poly-L-lysine-coated coverslips. Cells were then fixed for 10 min at 25 1C with 4% (wt/vol) paraformaldehyde and were made permeable for 10 min at 25 1C with permeabilization buffer (0.1% (vol/vol) Triton X-100 and 5% (vol/vol) FBS in PBS, pH 7.5). Cells were incubated for 30 min at 25 1C with anti-PKC-y or anti-PDK1 and then were incubated with donkey or goat secondary antibodies conjugated to Alexa Fluor 488 or Alexa Fluor 547 in identical conditions. Results were analyzed with a Zeiss Axiophot microscope or by LSM510 confocal microscopy.
Nuclear extract preparation and electrophoretic mobility-shift analyses. Purified primary CD4 + T cells (2 Â 10 6 ) were washed in PBS and were resuspended in 1 ml hypotonic lysis buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA and protease inhibitors). Cells were incubated on ice for 15 min. Triton X-100 was added to a final concentration of 1%, then cells were vortexed vigorously, were incubated on ice for 10 min and centrifuged for 1 min. After centrifugation, the supernatant was removed and the pellet was resuspended with 10 ml nuclear extraction buffer (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA and protease inhibitors). The tube was agitated for 30 min at 4 1C and the mixture was centrifuged for 5 min. After centrifugation, the supernatant was saved as a nuclear extract, glycerol was added to a final concentration of 20% (vol/vol) and 3 ml of each extract was subjected to bandshift analysis. Electrophoretic mobility-shift analyses were done with the following oligonucleotides and binding buffers: NFAT oligonucleotide, 5¢-GCCCAAAGAGGAAAA TTTGTTTCATACAG-3¢; NFAT 5¢ binding buffer, 50 mM Tris-HCl, pH 7.5, 500 mM KCl, 2.5 mM MgCl 2 , 0.5 mM EDTA, 50% (vol/vol) glycerol, 250 mg/ml of poly(dI:dC), 5 mM dithiothreitol and 1 mg/ml of BSA; NF-kB oligonucleotide, 5¢-ACCAAGAGGGATTTCACCT AAATC-3¢; and NF-kB binding buffer, 25 mM Tris-HCl, pH 7.5, 5 mM EDTA, 250 mg/ml poly(dI:dC), 5 mM dithiothreitol and 1 mg/ml of BSA. Labeled probe (5 Â 10 5 c.p.m.) was used in each reaction, and band shifts were resolved by electrophoresis through 5.5% polyacrylamide gels in 0.5Â Tris-borate-EDTA running buffer.
